2D-QSAR Study of Thiazole derivatives as 5-Lipoxygenase inhibitors

Autores/as

  • Danilo Ariza-Rúa Universidad Tecnologica de Bolivar, Colombia, Colombia
  • Julio Hurtado Márquez Universidad Tecnologica de Bolivar, Colombia, Colombia
  • Humberto Marbello-Peña Universidad Tecnologica de Bolivar, Colombia, Colombia
  • Edisson Chavarro-Mesa Universidad Tecnológica de Bolívar, Colombia.
  • Liliana Carranza-López Universidad Libre - Seccional Barranquilla, Colombia

DOI:

https://doi.org/10.18687/LACCEI2024.1.1.1785

Palabras clave:

2D-QSAR models, Thiazole derivatives, 5-Lipoxygenase, anti-inflammatory drugs

Resumen

Abstract - The inhibition of 5-Lipoxygenase (5-LO) has become a rational approach for the development of anti-inflammatory drugs. This study aimed to work on a trending machine learning approach with an open-source data analysis Python script for the discovery of 5-lipoxygenase inhibitors (5-LOX) by building two-dimensional-quantitative structure–activity relationships (2D-QSAR) of a series of 59 Thiazole derivatives acting as inhibitors of 5-LOX. The generated 2D-QSAR model showed a good correlation coefficient of 0.626 and a good prediction coefficient of the test set of 0.621. The predictive ability of the 2D-QSAR models was assessed via external (test set with 12 compounds). The proposed model gave significant statistical quality.

Descargas

Publicado

2024-07-27

Número

Sección

Articles

Licencia

Licencia Creative Commons

Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional.

LACCEI conserva el copyright de todos los artículos publicados bajo los términos de su acuerdo de transferencia de copyright. Como titular del copyright, LACCEI distribuye los artículos al público bajo la Licencia Internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0 (CC BY-NC-SA 4.0).

Cómo citar

Ariza-Rúa, D., Hurtado Márquez, J., Marbello-Peña, H., Chavarro-Mesa, E., & Carranza-López, L. (2024). 2D-QSAR Study of Thiazole derivatives as 5-Lipoxygenase inhibitors. LACCEI, 1(10). https://doi.org/10.18687/LACCEI2024.1.1.1785

Artículos más leídos del mismo autor/a